These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11704387)

  • 1. Treatable causes of sudden death: not really "treatable" or not really the cause?
    Viskin S; Halkin A; Olgin JE
    J Am Coll Cardiol; 2001 Nov; 38(6):1725-7. PubMed ID: 11704387
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypertrophic cardiomyopathy with midcavitary obstruction: another substrate for ventricular tachycardia?
    Gerstenfeld EP
    J Cardiovasc Electrophysiol; 2010 Sep; 21(9):1000-1. PubMed ID: 20487115
    [No Abstract]   [Full Text] [Related]  

  • 3. What risk should justify implantable cardioverter defibrillator therapy?
    Schläpfer J; Kappenberger L; Fromer M
    Am J Cardiol; 1999 Mar; 83(5B):101D-103D. PubMed ID: 10089850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiarrhythmic drugs or implantable cardioverter defibrillators in heart failure: the "poor heart".
    Böcker D; Breithardt G
    Am J Cardiol; 1999 Mar; 83(5B):83D-87D. PubMed ID: 10089846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interview with S. Lévy. Apropos of recommendations on defibrillators. Interview by M. Hérida].
    Lévy S
    Presse Med; 1998 Nov; 27(37):1907-8. PubMed ID: 9858968
    [No Abstract]   [Full Text] [Related]  

  • 6. Secondary prevention of sudden death: the Dutch Study, the Antiarrhythmics Versus Implantable Defibrillator Trial, the Cardiac Arrest Study Hamburg, and the Canadian Implantable Defibrillator Study.
    Cappato R
    Am J Cardiol; 1999 Mar; 83(5B):68D-73D. PubMed ID: 10089843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiarrhythmic therapy for the prevention of sudden cardiac death.
    Cairns J; Kerr C; Teo K
    Can J Cardiol; 2000 Jun; 16 Suppl C():29C-33C. PubMed ID: 10887276
    [No Abstract]   [Full Text] [Related]  

  • 8. [Implantable defibrillators--current status of guidelines. Recognized and possible indications--prerequisites].
    Andresen D
    Fortschr Med; 1996 Apr; 114(11):128-32. PubMed ID: 8682425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiological impact of microvolt T-wave alternans in sudden cardiac death primary prevention.
    Daccarett M; Serafimovski N; Machado C
    Int J Cardiol; 2007 Jun; 119(1):127-8; author reply 129-30. PubMed ID: 17049385
    [No Abstract]   [Full Text] [Related]  

  • 10. Mortality benefits and the implantable cardioverter-defibrillator.
    Sweeney MO; Ruskin JN
    Circulation; 1994 Apr; 89(4):1851-8. PubMed ID: 8149550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Risk stratification for sudden cardiac death in post-infarct patients and in patients with dilated cardiomyopathy].
    Grimm W
    Z Kardiol; 2000; 89 Suppl 10():11-9; discussion 19-20. PubMed ID: 11151769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Over 10 years with an implantable cardioverter-defibrillator - a long term follow-up of 60 patients.
    Sterliński M; Przybylski A; Gepner K; Syska P; Maciag A; Lewandowski M; Kowalik I; Pytkowski M; Sitkowska-Rysiak E; Lichomski J; Szwed H; Sadowski Z
    Kardiol Pol; 2010 Sep; 68(9):1023-9. PubMed ID: 20859894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AICD automatic cardioverter defibrillator clinical update: 14 years experience in over 34,000 patients.
    Nisam S; Kaye SA; Mower MM; Hull M
    Pacing Clin Electrophysiol; 1995 Jan; 18(1 Pt 2):142-7. PubMed ID: 7724388
    [No Abstract]   [Full Text] [Related]  

  • 14. Circumstances and outcomes of sudden unexpected death in patients with high-risk myocardial infarction: implications for prevention.
    Ye S; Grunnert M; Thune JJ; Stephenson KM; Uno H; Finn PV; McMurray JJ; Velazquez EJ; Califf R; Pfeffer MA; Solomon SD
    Circulation; 2011 Jun; 123(23):2674-80. PubMed ID: 21606398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Malignant mitral valve prolapse: apropos of a case].
    Van Caenegem O; Chaudron JM; Scavée C; de Meester A
    Acta Clin Belg; 1996; 51(6):403-8. PubMed ID: 9027190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ventricular arrhythmias and sudden cardiac death in adults with congenital heart disease.
    Khairy P
    Heart; 2016 Nov; 102(21):1703-1709. PubMed ID: 27250216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and MADIT-II.
    Klein H; Auricchio A; Reek S; Geller C
    Am J Cardiol; 1999 Mar; 83(5B):91D-97D. PubMed ID: 10089848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Appropriate Implantable Defibrillator Therapy in Adults With Hypertrophic Cardiomyopathy.
    Thavikulwat AC; Tomson TT; Knight BP; Bonow RO; Choudhury L
    J Cardiovasc Electrophysiol; 2016 Aug; 27(8):953-60. PubMed ID: 27138377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitachycardia pacing therapy for the successful treatment of lead fracture.
    Bhimani AA; Deeprasertkul P; Nannapaneni N; Carayannopoulos GN
    J Cardiovasc Electrophysiol; 2015 Feb; 26(2):228-9. PubMed ID: 25354719
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of sudden cardiac death in cardiac sarcoidosis using the wearable cardioverter defibrillator.
    Skowasch D; Ringquist S; Nickenig G; Andrié R
    PLoS One; 2018; 13(3):e0194496. PubMed ID: 29566033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.